In fact, IHC classification into BC subtypes based on hormone receptors (HR) such as estrogen and progesterone receptors, human epidermal growth factor receptor (HER2) and Ki67 is crucial for predicting BC survival5,6. This evidence concerns the gene ERBB2 and breast cancer.